Abstract

PurposeIt is unclear whether hypomagnesemia is an independent risk factor or innocent bystander for mortality in maintenance hemodialysis (MHD) patients. Thus, we studied associations between hypomagnesemia and all-cause as well as cardiovascular (CV) mortality in MHD patients.MethodsBaseline clinical characteristics and coronary artery calcium score (CACS) of 353 Japanese MHD patients were reviewed. Three-year survival rate and mortality risk factors were assessed.ResultsMedian (interquartile range) age, dialysis vintage, serum magnesium (Mg), serum albumin and CACS of the subjects were 68 (60–78) years, 75 (32–151) months, 2.4 (2.2–2.7) mg/dl, 3.6 (3.3–3.8) g/dl, and 1181 (278–3190), respectively. During the 3-year period, 91 patients died. Kaplan–Meier overall 3-year survival rates were 59.0% in in patients with Mg < 2.4 mg/dl (n = 136) and 82.3% in patients with Mg ≥ 2.4 mg/dl (n = 217), (P < 0.0001). In Cox regression models not incorporating serum albumin, Mg < 2.4 mg/dl was significantly associated with 3-year all-cause death, independent of age, dialysis vintage, average ultrafiltration, Log (CACS + 1), warfarin use, serum potassium, high-sensitivity C-reactive protein (hsCRP), phosphate, uric acid, and intact parathyroid hormone [Hazard ratio (HR) 95% confidence interval (CI): 2.82 (1.31–6.29), P = 0.0078], and CV death, independent of age, dialysis vintage, Log (CACS + 1), warfarin use, serum hsCRP, and uric acid [HR (95% CI): 4.47 (1.45–16.76), P = 0.0086]. Nevertheless, associations of Mg < 2.4 mg/dl with all-cause and CV mortality were all absent in models that included serum albumin.ConclusionsHypomagnesemia is not an independent risk factor for mortality but is associated with malnutrition in MHD patients.

Highlights

  • Vascular calcification is common in hemodialysis (HD) patients and increases the risk of cardiovascular (CV) disease [1]

  • Our study showed that age, dialysis vintage, average ultrafiltration, frequency of warfarin use, serum potassium, high-sensitivity C-reactive protein (hsCRP), phosphate, uric acid, albumin, and fibroblast growth factor 23 (FGF23) levels were significantly different among the four groups (P < 0.05)

  • Our study showed worse 3-year cumulative overall survival for all-cause and CV death in patients with hypomagnesemia (Mg < 2.4 mg/dl); the significance was lost when serum albumin quartile was incorporated in the models

Read more

Summary

Introduction

Vascular calcification is common in hemodialysis (HD) patients and increases the risk of cardiovascular (CV) disease [1]. Interest has grown in the relationships between serum magnesium (Mg) levels and vascular calcification or mortality in HD patients [2]. Clinical studies have produced inconsistent results regarding the association between Mg levels and mortality, partly because hypomagnesemia is linked to an increased frequency of co-morbidities. It is unclear whether hypomagnesemia causes increased mortality as an independent risk factor or as an “innocent bystander” [11]. This study was undertaken to investigate the associations between hypomagnesemia and all-cause as well as CV mortality in maintenance hemodialysis (MHD) patients

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call